TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.65, sa.4, ss.271-281, 2017 (ESCI)
Introduction: Colistimethate sodium (CMS) is frequently used in the treatment of nosocomial multidrug-resistant gram-negative infections. Nephrotoxicity is the most important side effect. The aim of this study is to evaluate the effect of colistin on nephrotoxicity and to assess prognosis in patients treated with CMS due to hospital-acquired pneumonia (HAP).